Next Generation Site Identification, From Theory to Practice

Application of Human Data


December 1, 2017
Next Generation Site Identification
The novel application of real-world data, statistical analysis, machine learning and predictive modeling has the potential to improve site identification for clinical trials – a process that still relies heavily on key opinion leaders (KOLs), historical experience and assumptions. This AccessPoint article includes use cases that quantify how these resources are accelerating site identification, improving patient enrollment rates and saving operational costs.
Future Clinical Development Insights